Recently, the paraoxonase (PON) family has emerged as a new class of antioxidant enzymes, playing an important role in obesity-associated illnesses, including cardiovascular disease (CVD) and diabetes mellitus; in particular, being present on the surface of high density lipoproteins (HDL), PON1 protects low density lipoproteins (LDL), and circulating cells against oxidative damage, thus preventing inflammatory responses in arterial wall cells. The gene discussed is PON1; the disease is obesity disorder.